On December 9, during an investor interaction, Harbin Pharmaceutical Group (600664) stated that it continues to expand its major product lines in the health supplement sector. The health technology division currently focuses on the following categories: liquid nutrition (Harbin Health brand, Sanjing Yangrun, etc.), bone and joint health (Gai Zhong Gai series), women’s health and appearance management (Puxue brand), and family dietary nutrition (Harbin Health brand). In particular, the market share of liquid nutrition is among the top in the industry, providing strong support for the company to enhance its market competitiveness through brand advantages and product resources. (Source: Synbio)
Sign Up to Receive China Updates Weekly Newsletter for FREE, HERE
Visit HPA-China’s Information Hub, HERE